Experts Predict Spike In Drug Recalls As US FDA Inspections Resume
Agency Expected To Focus Enforcement Efforts on COVID-19 Treatments
Executive Summary
Legal experts say any firm distributing products associated with COVID-19 should expect to receive the highest level of scrutiny as the US FDA resumes inspections and uses its enforcement muscle to prohibit companies from making adulterated products, such as hand sanitizers, or making fraudulent claims.